We are live on ! Find out more
GWM

Geneos Wealth Management Portfolio holdings

AUM $4.31B
1-Year Est. Return 18.36%
This Fund
S&P 500
This Quarter Est. Return
-12.88%
1 Year Est. Return
+18.36%
3 Year Est. Return
+53.76%
5 Year Est. Return
+60.8%
10 Year Est. Return
+204.74%
AUM
$2.02B
AUM Growth
-$304M
Cap. Flow
+$2.82M
Cap. Flow %
0.14%
Top 10 Hldgs %
20.11%
Holding
2,882
New
60
Increased
662
Reduced
773
Closed
206
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAT icon
101
Caterpillar
CAT
$375B
$4.89M 0.24%
27,458
-205
-0.7% -$43.2K
CMG icon
102
Chipotle Mexican Grill
CMG
$47.2B
$4.88M 0.24%
186,700
-2,950
-2% -$82.2K
NVDA icon
103
NVIDIA
NVDA
$4.86T
$4.87M 0.24%
335,380
+57,880
+21% +$1.09M
SPYM
104
State Street SPDR Portfolio S&P 500 ETF
SPYM
$161B
$4.69M 0.23%
104,648
+34,625
+49% +$1.67M
XLRE icon
105
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.55B
$4.69M 0.23%
112,742
-10,263
-8% -$458K
PAMC icon
106
Pacer Lunt MidCap Multi-Factor Alternator ETF
PAMC
$53.7M
$4.64M 0.23%
153,664
+4,938
+3% +$159K
AAAU icon
107
Goldman Sachs Physical Gold ETF Shares
AAAU
$2.46B
$4.54M 0.22%
253,321
-4,435
-2% -$82.5K
VEA icon
108
Vanguard FTSE Developed Markets ETF
VEA
$229B
$4.53M 0.22%
110,890
+6,375
+6% +$283K
KLAC icon
109
KLA
KLAC
$239B
$4.48M 0.22%
151,230
+5,690
+4% +$191K
IYR icon
110
iShares US Real Estate ETF
IYR
$4.66B
$4.44M 0.22%
47,415
-4,470
-9% -$446K
GILD icon
111
Gilead Sciences
GILD
$162B
$4.41M 0.22%
70,732
-5,943
-8% -$368K
LLY icon
112
Eli Lilly
LLY
$1.02T
$4.41M 0.22%
13,570
-312
-2% -$93.7K
VTIP icon
113
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.1B
$4.34M 0.21%
87,121
-667
-0.8% -$33.7K
ADP icon
114
Automatic Data Processing
ADP
$106B
$4.31M 0.21%
20,223
+819
+4% +$179K
AESR icon
115
Anfield US Equity Sector Rotation ETF
AESR
$241M
$4.29M 0.21%
384,241
-159,075
-29% -$1.93M
NKE icon
116
Nike
NKE
$61.9B
$4.23M 0.21%
41,851
+1,560
+4% +$184K
DHR icon
117
Danaher
DHR
$137B
$4.22M 0.21%
18,441
+294
+2% +$67.7K
IBM icon
118
IBM
IBM
$211B
$4.13M 0.2%
29,300
+25
+0.1% +$3.37K
EMR icon
119
Emerson Electric
EMR
$83.9B
$4.13M 0.2%
51,350
+4,670
+10% +$412K
SPMD icon
120
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
$18.2B
$4.07M 0.2%
101,207
+25,262
+33% +$1.1M
AJG icon
121
Arthur J. Gallagher & Co
AJG
$64.1B
$3.97M 0.2%
24,104
+760
+3% +$126K
EEM icon
122
iShares MSCI Emerging Markets ETF
EEM
$28.8B
$3.97M 0.2%
99,586
+1,916
+2% +$80.4K
ACN icon
123
Accenture
ACN
$102B
$3.91M 0.19%
13,918
+327
+2% +$98.3K
STZ icon
124
Constellation Brands
STZ
$22.2B
$3.85M 0.19%
16,335
+1,540
+10% +$375K
DVY icon
125
iShares Select Dividend ETF
DVY
$23.5B
$3.84M 0.19%
32,189
+2,352
+8% +$294K

Similar funds

Geneos Wealth Management's Q2 2022 Portfolio in Review

As of Q2 2022, Geneos Wealth Management held 2,882 positions worth $2.02B, down 13% from $2.33B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Geneos Wealth Management's Q2 2022 filing shows 60 new, 662 increased, 773 reduced and 206 closed positions. Its largest new stake was iShares MSCI Germany ETF: 78,679 shares worth $1.81M. The largest sale was Uncommon Portfolio Design Core Equity ETF, an estimated $12.6M.

By sector, the portfolio is most concentrated in Technology at 8.8% of assets, down from 9.6% a quarter earlier, followed by Financials and Healthcare.

  • Geneos Wealth Management's largest Q2 2022 buy was iShares MSCI Germany ETF: 78,679 shares worth $1.81M.
  • Geneos Wealth Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2022, an estimated $11.8M increase.
  • Geneos Wealth Management's biggest Q2 2022 reduction was Uncommon Portfolio Design Core Equity ETF, cutting an estimated $12.6M.
  • Geneos Wealth Management fully exited ProShares Ultra S&P500 in Q2 2022, selling an estimated $1.65M.
  • Geneos Wealth Management's ten largest holdings make up 20% of its $2.02B portfolio in Q2 2022.
  • Geneos Wealth Management opened 60 new positions and closed 206 in Q2 2022.
  • Geneos Wealth Management's portfolio value fell 13% quarter-over-quarter to $2.02B.

Based on Geneos Wealth Management's 13F filing for Q2 2022, filed 22 Jul 2022.